SCHEMBL4747154

SCHEMBL4747154

Cn1nc2ccc(S(=O)(=O)Cl)cc2n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CA12 O43570 2/20 0.36
CA9 Q16790 2/20 0.36
CA1 P00915 2/20 0.36
CA2 P00918 1/20 0.36
NMT1 P30419 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
NOTUM Q6P988 1/20 0.32
ACSS2 Q9NR19 2/20 0.32
LMNA P02545 1/20 0.31
HTT P42858 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
ATM Q13315 1/20 0.31
CYP1A2 P05177 1/20 0.31
GAA P10253 1/20 0.31
CNR2 P34972 1/20 0.30
TAS2R14 Q9NYV8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4750976 0.81 CASP3 (0.40) ALDH1A1HSD17B10TDP1CA12CA9
SCHEMBL30586438 0.74 HCAR3 (0.51) ALDH1A1HSD17B10MEN1KMT2ASMN1; SMN2
SCHEMBL26231079 0.74 HCAR3 (0.51) ALDH1A1HSD17B10MEN1KMT2ASMN1; SMN2
SCHEMBL30991749 0.74 DYRK1A (0.45) ALDH1A1NOTUMLMNAHTTGAA
SCHEMBL30586435 0.74 HCAR3 (0.51) ALDH1A1HSD17B10MEN1KMT2ASMN1; SMN2
SCHEMBL25212713 0.74 DYRK1A (0.45) ALDH1A1NOTUMLMNAHTTGAA
SCHEMBL5343737 0.74 ALDH1A1 (0.48) ALDH1A1HSD17B10KMT2ALMNAHTT
SCHEMBL31195035 0.73 CA12 (0.51) ALDH1A1CA12CA9CA1CA2
SCHEMBL32662709 0.73 SMN1; SMN2 (0.51) ALDH1A1CA12CA9CA1CA2
SCHEMBL25702661 0.73 LMNA (0.47) ALDH1A1CA12CA9CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008124524-A2 ARYL SULFONAMIDE COMPOUNDS AS MODULATORS OF THE CCK2 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2008-10-16 WO disclosed